Trial intelligence / Profile preview

Target-controlled infusion for propofol anesthesia during TIPS procedure

PACTR202310626983365Phase 4Recruiting

Sponsor
National Liver Institute
Start
Jul 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of propofol (2 arms), sponsored by National Liver Institute. Primary endpoint: SedLine reading and level of sedation. Started Jul 2023; status: recruiting.

02

Drugs

propofol

Beyond the preview

Go deeper on PACTR202310626983365.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202310626983365.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call